SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023441
Filing Date
2017-11-13
Accepted
2017-11-13 09:26:38
Documents
61
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20170930.htm 10-Q 1716541
2 EX-31.1 arpo-ex311_6.htm EX-31.1 20031
3 EX-31.2 arpo-ex312_7.htm EX-31.2 21270
4 EX-32.1 arpo-ex321_9.htm EX-32.1 10517
5 EX-32.2 arpo-ex322_8.htm EX-32.2 11744
  Complete submission text file 0001564590-17-023441.txt   5709538

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20170930.xml EX-101.INS 1099300
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20170930.xsd EX-101.SCH 43767
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20170930_cal.xml EX-101.CAL 31896
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20170930_def.xml EX-101.DEF 132605
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20170930_lab.xml EX-101.LAB 339903
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20170930_pre.xml EX-101.PRE 266170
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53057 | Film No.: 171193633
SIC: 2834 Pharmaceutical Preparations